Lifeward (LFWD) Net Cash Flow (QoQ) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lifeward | 5.59 Mn | -5.81 Mn | 1.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,726.56% |
| Dec 31, 2025 | 107.38% |
| Sep 30, 2025 | -444.76% |
| Jun 30, 2025 | 42.75% |
| Mar 31, 2025 | 73.95% |
| Dec 31, 2024 | 10.99% |
| Sep 30, 2024 | 20.62% |
| Jun 30, 2024 | 26.80% |
| Mar 31, 2024 | -68.16% |
| Dec 31, 2023 | 82.12% |
| Sep 30, 2023 | -585.84% |
| Jun 30, 2023 | 38.02% |
| Mar 31, 2023 | 3.63% |
| Dec 31, 2022 | -30.04% |
| Sep 30, 2022 | -30.05% |
| Jun 30, 2022 | 35.49% |
| Mar 31, 2022 | -98.23% |
| Dec 31, 2021 | -110.67% |
| Sep 30, 2021 | 951.75% |
| Jun 30, 2021 | -106.73% |
| Mar 31, 2021 | 1,929.94% |
| Dec 31, 2020 | -41.89% |
| Sep 30, 2020 | 254.31% |
| Jun 30, 2020 | -860.29% |
| Mar 31, 2020 | 108.18% |
| Dec 31, 2019 | -12.02% |
| Sep 30, 2019 | -124.42% |
| Jun 30, 2019 | 2,357.06% |
| Mar 31, 2019 | -115.73% |
| Dec 31, 2018 | 210.77% |
| Sep 30, 2018 | -1,551.88% |
| Jun 30, 2018 | 104.62% |
| Mar 31, 2018 | -449.85% |
| Dec 31, 2017 | 149.37% |
| Sep 30, 2017 | -287.89% |
| Jun 30, 2017 | 86.84% |
| Mar 31, 2017 | -154.10% |
| Dec 31, 2016 | 467.17% |
| Sep 30, 2016 | 46.32% |
| Jun 30, 2016 | -255.41% |
| Mar 31, 2016 | 154.20% |
| Dec 31, 2015 | -221.88% |
| Sep 30, 2015 | 0.35% |
| Jun 30, 2015 | 222.13% |
| Mar 31, 2015 | -699.26% |
| Dec 31, 2014 | -98.61% |
| Sep 30, 2014 | 1,434.47% |
| Dec 31, 2013 | -122.77% |